Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 73 of 102, showing 5 Applications out of 508 total, starting on record 361, ending on 365

# Protocol No Study Title Investigator(s) & Site(s)

361.

ECCT/15/12/01   A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY)
        Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya.   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county)
2. Sirisia, Chwele, Bokoli (Bung\'oma county)
3. Makunga, Mumias (Kakamega county)
 
View

362.

ECCT/15/06/04   A5316
        A5316           Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy   
Principal Investigator(s)
1. Dr. Esther Mumbi Makanga Makanga
2. Dr. Victor Akelo Akelo
3. Dr.Victor O. Mudhune Mudhune
4. Dr. Kevin P. Cain Cain
Site(s) in Kenya
KEMRI- CDC
 
View

363.

ECCT/18/11/01   PrIMA
              PrEP Implementation for Mothers in Antenatal Care            
Principal Investigator(s)
1. Grace John-Stewart John-Stewart
2. Jared Baeten
Site(s) in Kenya
1. Homa Bay County - 10 sites (Homa Bay county)
2. Siaya County - 10 sites (Siaya county)
 
View

364.

ECCT/25/02/03   NOZE20240219TB
    “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”.   
Principal Investigator(s)
1. Ibrahim Daud
Site(s) in Kenya
KEMRI/WRP CRC Kericho
 
View

365.

ECCT/22/03/08   CVIA 092
    “ A Phase 3 Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Safety (Ages 6 Months to 45 Years) and Non-inferiority (Ages 9-12 Months) of Multi-dose and Single-dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) against Typbar TCV® and Lot-to-Lot Consistency of the Immune Response (Ages 9-12 Months) to Multi-dose Vial Formulation EuTCV in Healthy African Participants”.    
Principal Investigator(s)
1. Dr Lucy Koech Chepkurui Koech
Site(s) in Kenya
KEMRI/ KERICHO CRC
 
View